Heat shock protein 60 reactive T cells in juvenile idiopathic arthritis: what is new?

[1]  E. Benarroch Heat shock proteins , 2011, Neurology.

[2]  A. Liston,et al.  Regulatory T Cells , 2011, Methods in Molecular Biology.

[3]  Hannu Kautiainen,et al.  Arthritis Research & Therapy , 2009 .

[4]  S. Zheng,et al.  Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. , 2008, Trends in immunology.

[5]  D. Vignali,et al.  How regulatory T cells work , 2008, Nature Reviews Immunology.

[6]  I. Cohen,et al.  Immunological efficacy of heat shock protein 60 peptide DiaPep277TM therapy in clinical type I diabetes , 2008, Clinical and experimental immunology.

[7]  T. Nomura,et al.  Regulatory T Cells and Immune Tolerance , 2008, Cell.

[8]  L. Wagner-Weiner Pediatric Rheumatology for the Adult Rheumatologist , 2008, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[9]  W. van Eden,et al.  Autoantigen-Specific IL-10-Transduced T Cells Suppress Chronic Arthritis by Promoting the Endogenous Regulatory IL-10 Response1 , 2008, The Journal of Immunology.

[10]  K. Mills,et al.  TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours , 2008, Oncogene.

[11]  Charles Schmidt Clinical setbacks for toll-like receptor 9 agonists in cancer , 2007, Nature Biotechnology.

[12]  A. Sette,et al.  Differential recognition of heat-shock protein dnaJ-derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis. , 2007, Arthritis and rheumatism.

[13]  I. Cohen,et al.  Therapy with the hsp60 peptide DiaPep277™ in C‐peptide positive type 1 diabetes patients , 2007, Diabetes/metabolism research and reviews.

[14]  J. Bluestone,et al.  Adaptive TGF-β-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment , 2007, Proceedings of the National Academy of Sciences.

[15]  Irun R Cohen,et al.  Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. , 2007, The Journal of clinical investigation.

[16]  Bernhard Fleischer,et al.  Synergistic and Differential Modulation of Immune Responses by Hsp60 and Lipopolysaccharide* , 2007, Journal of Biological Chemistry.

[17]  T. Huizinga,et al.  Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells , 2007, European journal of immunology.

[18]  E. Hoppenreijs,et al.  Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study , 2006, Annals of the rheumatic diseases.

[19]  Christopher H Contag,et al.  Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease. , 2006, Blood.

[20]  Alberto Martini,et al.  JUVENILE IDIOPATHIC ARTHRITIS , 2005, Archives of disease in childhood - Education & practice edition.

[21]  I. Cohen,et al.  Therapy with the hsp 60 peptide DiaPep 277 TM in C-peptide positive type 1 diabetes patients , 2007 .

[22]  C. Contag,et al.  Early CD 30 signaling is critical for adoptively transferred CD 4 CD 25 regulatory T cells in prevention of acute graft-versus-host disease , 2007 .

[23]  S. Albani,et al.  Modulation of T Cell Function by Combination of Epitope Specific and Low Dose Anticytokine Therapy Controls Autoimmune Arthritis , 2006, PloS one.

[24]  R. Steinman,et al.  Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients. , 2006, Blood.

[25]  A. Akbar,et al.  Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo , 2006 .

[26]  Guy Tal,et al.  Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. , 2006, The Journal of clinical investigation.

[27]  L. Joosten,et al.  Identification of Small Heat Shock Protein B8 (HSP22) as a Novel TLR4 Ligand and Potential Involvement in the Pathogenesis of Rheumatoid Arthritis1 , 2006, The Journal of Immunology.

[28]  F. Liew,et al.  Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[29]  G. Panayi,et al.  BiP regulates autoimmune inflammation and tissue damage. , 2006, Autoimmunity reviews.

[30]  J. Dehoorne,et al.  Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis. , 2006, Rheumatology.

[31]  M. Mann,et al.  Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6 , 2006, Nature.

[32]  A. Shaw,et al.  Triggering TLR signaling in vaccination. , 2006, Trends in immunology.

[33]  G. Stoll,et al.  Effective treatment of adjuvant arthritis with a stimulatory CD28-specific monoclonal antibody. , 2006, The Journal of rheumatology.

[34]  A. Akbar,et al.  Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. , 2006, The Journal of clinical investigation.

[35]  M. Levings,et al.  Human CD4+ T Cells Express TLR5 and Its Ligand Flagellin Enhances the Suppressive Capacity and Expression of FOXP3 in CD4+CD25+ T Regulatory Cells1 , 2005, The Journal of Immunology.

[36]  S. Albani,et al.  Recent developments in immunomodulatory peptides in juvenile rheumatic diseases: from trigger to dimmer? , 2005, Current opinion in rheumatology.

[37]  A. Sette,et al.  Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis , 2005, The Lancet.

[38]  B. Prakken,et al.  Heat-shock proteins induce T-cell regulation of chronic inflammation , 2005, Nature Reviews Immunology.

[39]  C. Gianfrani,et al.  IL‐10‐Producing T Regulatory Type 1 Cells and Oral Tolerance , 2004, Annals of the New York Academy of Sciences.

[40]  Irun R Cohen,et al.  Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein. , 2004, Arthritis and rheumatism.

[41]  T. Mak,et al.  CD30/CD30 Ligand (CD153) Interaction Regulates CD4+ T Cell-Mediated Graft-versus-Host Disease1 , 2004, The Journal of Immunology.

[42]  M. Tsan,et al.  Heat shock protein and innate immunity. , 2004, Cellular & molecular immunology.

[43]  W. Kuis,et al.  CD4+CD25bright Regulatory T Cells Actively Regulate Inflammation in the Joints of Patients with the Remitting Form of Juvenile Idiopathic Arthritis , 2004, The Journal of Immunology.

[44]  M. Suarez‐Almazor,et al.  International League of Associations for Rheumatology: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 , 2004 .

[45]  G. Tellides,et al.  CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism. , 2004, The Journal of clinical investigation.

[46]  D. Adorno,et al.  CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response. , 2003, Transplant immunology.

[47]  I. Cohen,et al.  T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  Anna Chodos,et al.  Antigen-dependent Proliferation of CD4+ CD25+ Regulatory T Cells In Vivo , 2003, The Journal of experimental medicine.

[49]  S. Kamphuis,et al.  The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. , 2003, Arthritis and rheumatism.

[50]  K. Asadullah,et al.  Interleukin-10 Therapy—Review of a New Approach , 2003, Pharmacological Reviews.

[51]  A. Mowat,et al.  Anatomical basis of tolerance and immunity to intestinal antigens , 2003, Nature Reviews Immunology.

[52]  I. Caramalho,et al.  Regulatory T Cells Selectively Express Toll-like Receptors and Are Activated by Lipopolysaccharide , 2003, The Journal of experimental medicine.

[53]  R. Jack,et al.  Macrophages as main inducers of IFN-gamma in T cells following administration of human and mouse heat shock protein 60. , 2002, International immunology.

[54]  W. van Eden,et al.  Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope. , 2002, Arthritis and rheumatism.

[55]  Carsten J. Kirschning,et al.  Endocytosed HSP60s Use Toll-like Receptor 2 (TLR2) and TLR4 to Activate the Toll/Interleukin-1 Receptor Signaling Pathway in Innate Immune Cells* , 2001, The Journal of Biological Chemistry.

[56]  F. Schumann,et al.  The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis. , 2001, Arthritis and rheumatism.

[57]  G. Pizzolo,et al.  Role of CD30+ T cells in rheumatoid arthritis: a counter-regulatory paradigm for Th1-driven diseases. , 2001, Trends in immunology.

[58]  M. Roncarolo,et al.  Differentiation of T Regulatory Cells by Immature Dendritic Cells , 2001, The Journal of experimental medicine.

[59]  H. Ochs,et al.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.

[60]  A Sette,et al.  Tools of the Trade in Vaccine Design , 2000, Science.

[61]  H. Weiner,et al.  Oral tolerance, an active immunologic process mediated by multiple mechanisms. , 2000, The Journal of clinical investigation.

[62]  Mahavir Singh,et al.  A Conserved Mycobacterial Heat Shock Protein (hsp) 70 Sequence Prevents Adjuvant Arthritis upon Nasal Administration and Induces IL-10-Producing T Cells That Cross-React with the Mammalian Self-hsp70 Homologue1 , 2000, The Journal of Immunology.

[63]  H. Kolb,et al.  Cutting Edge: Heat Shock Protein 60 Is a Putative Endogenous Ligand of the Toll-Like Receptor-4 Complex1 , 2000, The Journal of Immunology.

[64]  Y. Yoshikai,et al.  Activation of T cells recognizing an epitope of heat-shock protein 70 can protect against rat adjuvant arthritis. , 1999, Journal of immunology.

[65]  F. Breedveld,et al.  Analysis of serial synovial biopsies in patients with rheumatoid arthritis: description of a control group without clinical improvement after treatment with interleukin 10 or placebo. , 1999, The Journal of rheumatology.

[66]  J. Goodall,et al.  T cell responses to heat-shock protein 60: differential responses by CD4+ T cell subsets according to their expression of CD45 isotypes. , 1999, Journal of immunology.

[67]  W. Kuis,et al.  Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. , 1996, Arthritis and rheumatism.

[68]  C. Morris,et al.  A synthetic 10‐kD heat shock protein (hsp10) from Mycobacterium tuberculosis modulates adjuvant arthritis , 1996, Clinical and experimental immunology.

[69]  P. Helders,et al.  Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis. , 1995, The Journal of clinical investigation.

[70]  W. van Eden,et al.  Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis , 1995, The Journal of experimental medicine.

[71]  R. Gupta,et al.  Adjuvants for human vaccines--current status, problems and future prospects. , 1995, Vaccine.

[72]  S. Albani,et al.  Immune responses to the Escherichia coli dnaJ heat shock protein in juvenile rheumatoid arthritis and their correlation with disease activity. , 1994, The Journal of pediatrics.

[73]  P. Matzinger Tolerance, danger, and the extended family. , 1994, Annual review of immunology.

[74]  E. Craig,et al.  Heat shock proteins: molecular chaperones of protein biogenesis , 1993, Microbiological reviews.

[75]  W. van Eden,et al.  Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis , 1992, The Journal of experimental medicine.

[76]  J. Bijlsma,et al.  Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis , 1991, The Lancet.

[77]  I. Cohen,et al.  Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[78]  Ellis Rj The molecular chaperone concept. , 1990 .

[79]  R. Ellis,et al.  The molecular chaperone concept. , 1989, Biochemical Society symposium.

[80]  I. Cohen,et al.  Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis , 1988, Nature.